Skip to main content
Figure 3 | Journal of Translational Medicine

Figure 3

From: ARA290, a non-erythropoietic EPO derivative, attenuates renal ischemia/reperfusion injury

Figure 3

Effect of ARA290 on structural damage. The morphology of ischemic kidneys at seven days post-reperfusion is shown by a PAS staining in representative sections of control group (3A) and ARA290 treated group (3B). ARA290 attenuated morphological injury at seven days post-reperfusion. Immunohistochemical α-SMA staining shows expression at seven days post-reperfusion in the control group (3C) and the ARA290 treated group (3D).

Back to article page